OBJECTIVE: Obesity is a risk factor for non-alcoholic steatohepatitis (NASH). This risk has been attributed to visceral adipose tissue (vAT) expansion associated with increased proinflammatory mediators. Accumulation of CD11c+ proinflammatory adipose tissue macrophages (ATM) is an important driver of vAT inflammation. We investigated the role of ATMs in hepatic inflammation during NASH development. DESIGN: vAT isolated from lean, obese or ATM-depleted (using clodronate liposomes) obese mice was transplanted to lean ldlr-/- acceptor mice. Systemic and hepatic inflammation was assessed either after 2 weeks on standard chow or after 8 weeks on high cholesterol diet (HCD) to induce NASH. RESULTS: Transplanting donor vAT from obese mice increase...
Objective: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and diabetes, suggesting an...
Macrophage-mediated inflammation is critical in the pathogenesis of non-alcoholic steatohepatitis (N...
OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and diabetes, suggesting an...
Objective Obesity is a risk factor for non-alcoholic steatohepatitis (NASH). This risk has been attr...
Obesity is a complex metabolic disorder associated with the development of non-communicable diseases...
Nonalcoholic steatohepatitis (NASH) is characterized by extensive hepatic monocyte infiltration and ...
Abstract Background Obesity and inflammation are highly integrated processes in the pathogenesis of ...
Background: The prevalence of obesity is rising and leads to increased morbidity and mortality. Adip...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Wester...
The current dogma is that obesity-associated hepatic inflammation is due to increased Kupffer cell (...
Adipose tissue macrophages (ATMs) present in the epididymal white adipose tissue (EWAT) are separate...
Background and aims: Obese individuals have a higher risk of developing atherosclerosis, possibly dr...
Immune cell infiltration in visceral adipose tissue (VAT) during obesity is associated with local ch...
Macrophages play critical roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). However...
Objective: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and diabetes, suggesting an...
Macrophage-mediated inflammation is critical in the pathogenesis of non-alcoholic steatohepatitis (N...
OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and diabetes, suggesting an...
Objective Obesity is a risk factor for non-alcoholic steatohepatitis (NASH). This risk has been attr...
Obesity is a complex metabolic disorder associated with the development of non-communicable diseases...
Nonalcoholic steatohepatitis (NASH) is characterized by extensive hepatic monocyte infiltration and ...
Abstract Background Obesity and inflammation are highly integrated processes in the pathogenesis of ...
Background: The prevalence of obesity is rising and leads to increased morbidity and mortality. Adip...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Wester...
The current dogma is that obesity-associated hepatic inflammation is due to increased Kupffer cell (...
Adipose tissue macrophages (ATMs) present in the epididymal white adipose tissue (EWAT) are separate...
Background and aims: Obese individuals have a higher risk of developing atherosclerosis, possibly dr...
Immune cell infiltration in visceral adipose tissue (VAT) during obesity is associated with local ch...
Macrophages play critical roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). However...
Objective: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and diabetes, suggesting an...
Macrophage-mediated inflammation is critical in the pathogenesis of non-alcoholic steatohepatitis (N...
OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and diabetes, suggesting an...